NDC 51991-899 – Rivastigmine Transdermal System

Rivastigmine 13.3 mg/24h · Patch, Extended Release · Transdermal

Human Prescription Drug

Product NDC51991-899

Product details

Brand name
Rivastigmine Transdermal System
Generic name
Rivastigmine
Labeler
Breckenridge Pharmaceutical, Inc.
Dosage form
Patch, Extended Release
Route
Transdermal
Marketing category
ANDA · ANDA209063
Marketed since
December 19, 2019
Listing expires
December 31, 2026
Pharmacologic class
Cholinesterase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Rivastigmine Transdermal System →

Package NDC codes (1)

Package NDCDescriptionSince
51991-899-3030 POUCH in 1 CARTON (51991-899-30) / 1 PATCH in 1 POUCH (51991-899-99) / 24 h in 1 PATCHDec 19, 2019

Other Rivastigmine Transdermal System products